Welltower (NYSE:WELL) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Welltower (NYSE:WELL) issued its quarterly earnings data on Monday. The real estate investment trust reported $1.67 EPS for the quarter, topping the consensus estimate of $1.64 by $0.03, Zacks reports. Welltower had a return on equity of 3.56% and a net margin of 12.15%. During the same quarter last year, the business earned $1.34 earnings per share. The firm’s revenue was up 38.4% compared to the same quarter last year.

Welltower Trading Up 1.2%

Shares of WELL traded up $2.79 during trading hours on Monday, hitting $240.11. The company had a trading volume of 2,281,423 shares, compared to its average volume of 3,090,963. The firm has a market cap of $173.06 billion, a P/E ratio of 110.14, a P/E/G ratio of 1.15 and a beta of 0.75. The stock’s 50 day moving average price is $233.87 and its 200 day moving average price is $217.08. The company has a quick ratio of 3.16, a current ratio of 3.16 and a debt-to-equity ratio of 0.37. Welltower has a 52-week low of $174.91 and a 52-week high of $255.20.

Insiders Place Their Bets

In related news, Director Andrew Gundlach purchased 5,000 shares of Welltower stock in a transaction that occurred on Wednesday, August 26th. The shares were acquired at an average cost of $242.06 per share, for a total transaction of $1,210,300.00. Following the transaction, the director directly owned 30,000 shares in the company, valued at $7,261,800. The trade was a 20.00% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Purchased indirectly through two trusts. The transaction was executed in multiple trades at prices ranging from $241.59 to $242.59. The reported $242.06 price is the weighted-average purchase price. 0.37% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on WELL. KeyCorp lifted their price target on Welltower from $240.00 to $275.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 4th. Scotiabank upped their price objective on Welltower from $244.00 to $251.00 and gave the stock an “outperform” rating in a report on Wednesday, September 2nd. BMO Capital Markets increased their price objective on Welltower from $245.00 to $265.00 and gave the company an “outperform” rating in a research report on Monday, August 3rd. JPMorgan Chase & Co. upgraded Welltower from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $230.00 to $260.00 in a research report on Thursday, September 24th. Finally, Barclays decreased their price objective on Welltower from $259.00 to $246.00 and set an “equal weight” rating on the stock in a report on Tuesday, October 13th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Welltower currently has a consensus rating of “Moderate Buy” and an average target price of $255.86.

About Welltower

Welltower Inc (NYSE: WELL) is a healthcare-focused real estate investment trust that owns, develops, and manages properties used to provide healthcare and related services. Its portfolio is centered on senior housing communities, outpatient medical facilities, and post-acute care properties, including assets operated by healthcare providers and senior living companies.

The company’s senior housing investments support independent living, assisted living, and memory care services. Its outpatient medical properties accommodate physicians, clinics, and other healthcare providers, while its broader healthcare real estate portfolio is designed to serve demand for care delivered outside traditional hospitals.